Childhood Cancer Statistics in India

Summary of Childhood Cancer Issues in India

Key Findings:

• India accounts for 68.6% of new childhood cancer cases in the SAARC region, with 25,939 new cases and 17,698 deaths reported annually (2022).
• Leukaemia is the most prevalent childhood cancer (35-50% of cases), followed by central nervous system (CNS) tumors (~12%).
• The national cancer registry in India covers only 15% of the population, primarily urban areas, leading to underreporting in rural locations.

Health Statistics:

• Children under 14 years: Approximately 380 million in India.
• Cure rates: Childhood leukaemia can achieve 80-90% cure rates with early diagnosis; however, overall cure rates for childhood cancers are skewed due to socioeconomic factors, with less than 30% cure rates in low- and middle-income countries, compared to over 80% in high-income nations.

Challenges:

• Delayed diagnosis and advanced presentation of cancer significantly affect survival rates.
• Financial Constraints: High treatment costs can lead to abandonment, worsened by the failure of initial treatments.
• Need for a comprehensive cancer registry: Essential for accurate data, aiding in the identification of geographical patterns and factors affecting childhood cancer incidence.

Government Schemes and Policies:

• Ayushman Bharat scheme: Provides ₹5 lakh health cover per family, subsidizing initial treatment in government hospitals.
• As of August 11, 2026, the Supreme Court mandated all states and UTs to declare cancer as a notifiable disease to enhance data collection and reporting.

Recommendations:

• Enhance cancer registration and reporting practices to cover rural areas, aiming for a national registry capturing diagnosis, geographical origin, and treatment outcomes.
• Improve access to specialized healthcare and financial support for families undergoing treatment.
• Provide improved educational resources about the importance of early diagnosis and available treatment options.

Current Developments:

• Significant expansions of cancer treatment infrastructure across states, along with an increase in specialized paediatric oncology units, facilitating better access to care.
• Ongoing efforts by institutions like the Cancer Institute in Chennai to establish registries and improve information sharing among hospitals.

Conclusion:

To effectively combat childhood cancer in India, a multi-faceted approach focusing on early diagnosis, improved healthcare access, financial support, and comprehensive data collection is essential for increasing survival rates and improving outcomes for affected children and their families.